Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.3300 (-5.72%) ($14.2350 - $15.7550) on Thu. Jan. 20, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.03% (three month average) | RSI | 43 | Latest Price | $14.3300(-5.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -3.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) IBB(48%) ARKG(47%) ARKK(47%) IWM(43%) | Factors Impacting ATRA price | ATRA will decline at least -2.015% in a week (0% probabilities). VIXM(-42%) VXX(-31%) UNG(-18%) USO(-14%) UUP(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.015% (StdDev 4.03%) | Hourly BBV | -2.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $3.72(-74.04%) | Resistance Level | $15.84 | 5 Day Moving Average | $14.94(-4.08%) | 10 Day Moving Average | $15.19(-5.66%) | 20 Day Moving Average | $15.84(-9.53%) | To recent high | -28% | To recent low | 0.7% | Market Cap | $1.065b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |